303 related articles for article (PubMed ID: 20112166)
1. Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Pasqualotto AC; Thiele KO; Goldani LZ
Curr Opin Investig Drugs; 2010 Feb; 11(2):165-74. PubMed ID: 20112166
[TBL] [Abstract][Full Text] [Related]
2. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
3. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
4. Isavuconazole: a new extended spectrum triazole for invasive mold diseases.
Ananda-Rajah MR; Kontoyiannis D
Future Microbiol; 2015; 10(5):693-708. PubMed ID: 26000646
[TBL] [Abstract][Full Text] [Related]
5. Isavuconazonium sulfate for the treatment of fungal infection.
Walker RC; Zeuli JD; Temesgen Z
Drugs Today (Barc); 2016 Jan; 52(1):7-16. PubMed ID: 26937491
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
González GM
Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
[TBL] [Abstract][Full Text] [Related]
7. Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
Thompson GR; Wiederhold NP
Mycopathologia; 2010 Nov; 170(5):291-313. PubMed ID: 20524153
[TBL] [Abstract][Full Text] [Related]
8. New and investigational triazole agents for the treatment of invasive fungal infections.
De Sarro A; La Camera E; Fera MT
J Chemother; 2008 Dec; 20(6):661-71. PubMed ID: 19129062
[TBL] [Abstract][Full Text] [Related]
9. Posaconazole: a broad-spectrum triazole antifungal.
Torres HA; Hachem RY; Chemaly RF; Kontoyiannis DP; Raad II
Lancet Infect Dis; 2005 Dec; 5(12):775-85. PubMed ID: 16310149
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
Yamazaki T; Inagaki Y; Fujii T; Ohwada J; Tsukazaki M; Umeda I; Kobayashi K; Shimma N; Page MG; Arisawa M
Int J Antimicrob Agents; 2010 Oct; 36(4):324-31. PubMed ID: 20674282
[TBL] [Abstract][Full Text] [Related]
11. New and emerging treatments for fungal infections.
Pasqualotto AC; Denning DW
J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i19-30. PubMed ID: 18063600
[TBL] [Abstract][Full Text] [Related]
12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
13. New generation azole antifungals in clinical investigation.
Girmenia C
Expert Opin Investig Drugs; 2009 Sep; 18(9):1279-95. PubMed ID: 19678798
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections.
Livermore J; Hope W
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):759-65. PubMed ID: 22530880
[TBL] [Abstract][Full Text] [Related]
15. Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.
Denis J; Ledoux MP; Nivoix Y; Herbrecht R
J Mycol Med; 2018 Mar; 28(1):8-14. PubMed ID: 29534853
[TBL] [Abstract][Full Text] [Related]
16. Newer antifungal agents.
Türel O
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):325-38. PubMed ID: 21417872
[TBL] [Abstract][Full Text] [Related]
17. The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.
Chitasombat MN; Kontoyiannis DP
Expert Opin Pharmacother; 2015; 16(10):1543-58. PubMed ID: 26100603
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in vitro evaluation of novel antifungal triazoles.
Xie F; Ni T; Zhao J; Pang L; Li R; Cai Z; Ding Z; Wang T; Yu S; Jin Y; Zhang D; Jiang Y
Bioorg Med Chem Lett; 2017 May; 27(10):2171-2173. PubMed ID: 28372907
[TBL] [Abstract][Full Text] [Related]
20. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
